As the European Medicines Agency (EMA) releases its latest guidance on the safe use of large language models (LLMs) in regulatory science, Cyntegrity is excited to announce the Responsible AI in Clinical Trials Summit. Taking place on October 8-9, 2024, this free virtual event will address the growing importance of AI in clinical trials, exploring […]
continue reading
Cyntegrity Announces Upcoming Virtual Dialogue on „Responsible AI in Clinical Trials“
Cyntegrity, a front-runner in AI-augmented clinical trial risk management solutions, proudly announces its upcoming virtual conference on "Responsible AI in Clinical Trials," scheduled for November 15 and 16. This groundbreaking event is designed to bridge the knowledge gap and stimulate multistakeholder conversations on the responsible application of Artificial Intelligence in clinical research. Linda Bunschoten, Cyntegrity’s […]
continue readingCyntegrity’s MyRBQM Portal, an AI-Supported Clinical Trial Risk Management Solution, is Now Available in the Microsoft Azure Marketplace
Cyntegrity, a renowned provider of comprehensive clinical trial risk management (CTRM) solutions, today announced the availability of its transformative MyRBQM Portal in the Microsoft Azure Marketplace, an online store offering applications and services for use on Azure. This key development empowers customers worldwide to access and deploy this innovative risk management solution in a streamlined, […]
continue readingCyntegrity and PwC Germany Join Forces to Offer Comprehensive Risk-Based Quality Management Solutions to the Pharmaceutical Industry
Cyntegrity Germany GmbH and PricewaterhouseCoopers GmbH Wirtschaftsprüfungsgesellschaft (PwC) have entered into a cooperation agreement to offer innovative and complementary services to clients in the pharmaceutical industry. Cyntegrity’s cloud-based technology solution, the MyRBQM Portal, a risk-based quality management (RBQM) system, enables companies to improve their clinical operations, manage risks within clinical research activities, and speed up […]
continue readingmindsON RBQM | Episode 17: RBQM should be standardized, shouldn’t it? (Webinar | Online)
Language: English Time: 17.00 to 18.30 h (German time zone, CET) Price: 0 € (free of charge) Webinar: How much of RBQM can be standardized, and how much flexibility is still necessary? Some companies seem to always start from scratch, while others try to standardize as much as possible. What is right and what is […]
continue readingmindsON RBQM | Episode 16: RBQM implementation – Which existing roles need change, and what new ones (Webinar | Online)
Language: English Time: 17.00 to 18.30 h (German time zone, CET) Price: 0 € (free of charge) Webinar: Since Risk-Based Monitoring was introduced in 2013 by FDA and EMA, organizations have taken many different approaches to implementation. What activities typically need to be performed for RBQM to work well? Which roles usually perform these activities? […]
continue reading
mindsON RBQM | Episode 15: The Risk Assessment is easy, right? Wrong! (Webinar | Online)
Language: English Time: 17.00 to 18.30 h (German time zone, CET) Price: 0 € (free of charge) Webinar: Describe and discuss the practical challenges with risk assessment. How many risks should you have? Should risks that are for multiple studies be included? Should you only include risks that are study specific? Should the impact score […]
continue readingmindsON RBQM | Episode 14: QTLs – The Return! (Webinar | Online)
Language: English Time: 17.00 to 18.30 h (German time zone, CET) Price: 0 € (free of charge) Webinar: We ran a workshop on QTLs in 2022 and were inundated with questions. So we thought we needed to return to the subject! We will explore the latest thinking on QTLs, discuss why organizations find them so […]
continue reading
mindsON Global Risk Management | How Ukraine-based CRO adopts war as opportunity (Webinar | Online)
A War – A Low Probability Risk with High Impact In this special episode of mindsON Global Risk Management, our CEO, Artem Andrianov, Ph.D., speaks with Dr. Yuriy Lebed, the CEO of Pharmaxi LLC, a CRO based in Kyiv, Ukraine, that works with BioPharma and Medical Device companies across the globe. As a data science […]
continue readingUkraine-based Dr. Yuriy Lebed explains how his Contract Research Organization navigates global risk and adopts war as an opportunity to reach out to unique patient groups
What if we could predict and mitigate global risks such as pandemics, wars, and energy crises ahead of time? What would your organization look like? A real-life story about where global risk meets local opportunity. In a virtual interview with Dr. Yuriy Lebed, CEO of Pharmaxi LLC, a Ukraine-based CRO, and host Artem Andrianov, CEO […]
continue reading